Ecomerate vs Supertake: Thesis Monitoring vs Take-Based Portfolios (2026)
Supertake turns a plain-English take into a portfolio it trades in your brokerage account. Ecomerate keeps the thesis behind a position and texts you when a filing or earnings print changes it.
Want analysis like this for any stock?
Ecomerate's AI analyzes earnings calls, SEC filings, market data, and sentiment — delivering institutional-grade research in seconds.
Get startedDirect Answer
Supertake and Ecomerate start from the same thing, a belief about the market, and put the weight in different places. Supertake turns a plain-English take into a portfolio of US-listed securities and places and rebalances those trades in your linked brokerage account, either with your approval for each trade or on Autopilot within a dollar cap you set. Ecomerate starts from evidence. It is an AI research analyst you text in iMessage: it remembers why you hold a position, watches filings and earnings prints, texts first when one changes the thesis, and names the source. Automated trading is coming to Ecomerate soon. Pick Supertake to put an idea into a portfolio today. Pick Ecomerate to keep testing the idea against what the company discloses.
Key Takeaways
- • Execution today vs evidence first: Supertake sends trade instructions to your broker through an API today. Ecomerate is built around filing and earnings evidence, with automated trading coming soon.
- • Different feedback loops: Supertake reports how a take is performing. Ecomerate checks the thesis against new 10-Ks, 10-Qs, 8-Ks, and earnings releases and cites the document.
- • Surfaces: Supertake runs in a web app and over email, with iMessage and SMS announced but not live. Ecomerate runs in iMessage today, with no app to install.
- • Pricing: Supertake is free while it is in beta. Ecomerate publishes plans from $0 to $59.99 per month.
- • Access: Supertake is an invite-only beta with a waitlist. Ecomerate has a free plan.
Ecomerate vs Supertake at a Glance
| Ecomerate | Supertake | |
|---|---|---|
| What it is | AI research analyst you text in iMessage | AI investing agent that builds and trades portfolios from a written take |
| Main surface | iMessage; the website is only for your account | Web app and email; iMessage and SMS announced as coming soon |
| Places trades | Not yet; automated trading is coming soon | Yes, in your linked brokerage, with per-trade approval or Autopilot within a cap |
| Brokerage link | Coming soon; today you text it your positions | Robinhood, per its terms; other brokers may follow |
| Markets | Supported US equities and ETFs | US-listed equities today; crypto, derivatives, and prediction markets planned |
| Proactive messages | When a filing, earnings print, or disclosure change affects a position you follow | Updates on how a take is performing |
| Source citations | Names the filing, release, or note behind an answer | Not described on its public pages |
| Social features | None | Share and fork takes; public leaderboard |
| Practice mode | Not offered | Practice Mode with simulated funds |
| Price | Free, Starter $11.99, Trader $24.99, Ultimate $59.99 per month | Free during beta; its terms allow charges later |
| Access | Free plan; no app to install | Invite-only beta with a waitlist |
Supertake details come from its public pages as checked on October 19, 2026. Features and prices change, so confirm on the official site before you subscribe.
What Supertake Does
Supertake was incubated at Union Square Ventures and announced on September 28, 2026. You write a take in plain English, such as a view on an industry or a macro trend, and the agent builds a portfolio to express it. The examples on its homepage hold stocks, ETFs, and short-term Treasuries. It rebalances each take daily, and you can chat with a portfolio from the app or over email.
Execution is the core of the product. Supertake links to your brokerage account and sends trade instructions to the broker through its API. Its terms name Robinhood. You can approve trades one at a time, or turn on Autopilot, which trades without per-trade approval up to a dollar cap you set. Supertake does not take custody of your money, and its terms say it is neither a broker-dealer nor a registered investment adviser.
Around that sits a social layer. You can share a take, fork someone else's, and browse a public leaderboard. A Practice Mode runs takes on simulated funds before you commit real money.
What Ecomerate Does
Ecomerate starts after the decision. You text it the reason you own a company, and it keeps that thesis. When a new 10-Q, 8-K, or earnings release arrives, it reads the document against what you said and texts first if something in the case changed, such as a guidance cut, a new risk factor, or a shift in segment mix. When you ask where a claim came from, it names the filing, release, or note so you can open it yourself.
Text it your positions and it uses them in answers, alerts, and routines, and when you want depth it writes a research note as a PDF. Coverage focuses on supported US equities and ETFs. Brokerage connections and automated trading are coming soon.
The Real Difference: Acting on a Belief vs Testing It
Supertake measures a take by how its portfolio performs. That is useful feedback, but a price move does not tell you whether the reasoning still holds. A stock can rise while the thesis breaks, or fall while it is intact. Ecomerate measures the thesis against the company's own disclosures instead.
Autopilot makes that gap matter more. When an agent can trade without asking, the quality of the original take carries more weight, and so does noticing when its premise stops being true. Supertake's own terms say AI output may be inaccurate, incomplete, or outdated, and that leaderboard and practice returns may be simulated. Treat any automated portfolio, including one you wrote, as something to keep checking.
Using Them Together
Today the two products overlap little, so you can run both. Write and fund a take in Supertake, then text Ecomerate the thesis behind its largest holdings. When a filing or earnings print undercuts the take, the message reaches you in iMessage, and you decide whether to change it.
Which Should You Choose?
Choose Ecomerate if...
You already hold positions, or plan to, and want an agent that remembers why, reads each filing and earnings print against that reason, and cites the source, all by text.
Choose Supertake if...
You want to turn a market view into a real portfolio quickly, you use a supported broker such as Robinhood, and you are comfortable letting an agent place and rebalance trades with per-trade approval or on Autopilot.
Before You Rely on Either
Neither product is personalised investment advice. AI answers can be wrong, stale, or incomplete, so check material claims against the dated primary source. Ecomerate is not a broker.
Sources
Want an analyst in your messages?
Start free with 10 messages a week. Paid plans start with a 7-day free trial.
Frequently Asked Questions
Is Supertake free?
Supertake says the product is free to use while it is in beta. Its terms say it does not currently charge a subscription fee but may add charges later. Your broker's own fees still apply.
Does Ecomerate place trades like Supertake?
Not yet. Automated trading is coming to Ecomerate soon. Today you text it your positions, while Supertake already sends trade instructions to your linked broker.
Which brokers does Supertake support?
Its terms name a Robinhood connection and say other brokers may be added in the future. Its launch post also mentions Coinbase. Check the current app before you sign up.
Can I text Supertake in iMessage?
Not yet. Its launch post says you can talk to a portfolio from the app or over email, with iMessage and SMS coming soon. Ecomerate runs in iMessage today.
Does Supertake cite sources?
Its public pages do not describe source citations for portfolio decisions. Ecomerate names the filing, release, or note behind an answer when you ask.
What markets do they cover?
Supertake trades public US-listed equities today and has said crypto, derivatives, and prediction markets are planned. Ecomerate's research workflows focus on supported US equities and ETFs.